297 related articles for article (PubMed ID: 24072771)
1. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
Khan N; Bharali DJ; Adhami VM; Siddiqui IA; Cui H; Shabana SM; Mousa SA; Mukhtar H
Carcinogenesis; 2014 Feb; 35(2):415-23. PubMed ID: 24072771
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based nanoformulated (-)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis.
Chamcheu JC; Siddiqui IA; Adhami VM; Esnault S; Bharali DJ; Babatunde AS; Adame S; Massey RJ; Wood GS; Longley BJ; Mousa SA; Mukhtar H
Int J Nanomedicine; 2018; 13():4189-4206. PubMed ID: 30057446
[TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
4. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
Siddiqui IA; Bharali DJ; Nihal M; Adhami VM; Khan N; Chamcheu JC; Khan MI; Shabana S; Mousa SA; Mukhtar H
Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
[TBL] [Abstract][Full Text] [Related]
5. Nanochemoprevention: sustained release of bioactive food components for cancer prevention.
Siddiqui IA; Adhami VM; Ahmad N; Mukhtar H
Nutr Cancer; 2010; 62(7):883-90. PubMed ID: 20924964
[TBL] [Abstract][Full Text] [Related]
6. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
Nihal M; Ahmad N; Mukhtar H; Wood GS
Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
[TBL] [Abstract][Full Text] [Related]
8. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Spinella F; Rosanò L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
[TBL] [Abstract][Full Text] [Related]
10. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.
Siddiqui IA; Adhami VM; Bharali DJ; Hafeez BB; Asim M; Khwaja SI; Ahmad N; Cui H; Mousa SA; Mukhtar H
Cancer Res; 2009 Mar; 69(5):1712-6. PubMed ID: 19223530
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo.
Adhami VM; Malik A; Zaman N; Sarfaraz S; Siddiqui IA; Syed DN; Afaq F; Pasha FS; Saleem M; Mukhtar H
Clin Cancer Res; 2007 Mar; 13(5):1611-9. PubMed ID: 17332308
[TBL] [Abstract][Full Text] [Related]
12. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins.
Nishikawa T; Nakajima T; Moriguchi M; Jo M; Sekoguchi S; Ishii M; Takashima H; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
J Hepatol; 2006 Jun; 44(6):1074-82. PubMed ID: 16481065
[TBL] [Abstract][Full Text] [Related]
13. Nanochemoprevention by bioactive food components: a perspective.
Siddiqui IA; Mukhtar H
Pharm Res; 2010 Jun; 27(6):1054-60. PubMed ID: 20221894
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of green tea polyphenol EGCG((-)-epigallocatechin-3-gallate) on the proliferation of gastric cancer cells by suppressing canonical wnt/β-catenin signalling pathway.
Yang C; Du W; Yang D
Int J Food Sci Nutr; 2016 Nov; 67(7):818-27. PubMed ID: 27338284
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.
Sanna V; Singh CK; Jashari R; Adhami VM; Chamcheu JC; Rady I; Sechi M; Mukhtar H; Siddiqui IA
Sci Rep; 2017 Feb; 7():41573. PubMed ID: 28145499
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas.
Siddiqui IA; Zaman N; Aziz MH; Reagan-Shaw SR; Sarfaraz S; Adhami VM; Ahmad N; Raisuddin S; Mukhtar H
Carcinogenesis; 2006 Apr; 27(4):833-9. PubMed ID: 16387739
[TBL] [Abstract][Full Text] [Related]
17. The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells.
Zhou Y; Tang J; Du Y; Ding J; Liu JY
Tumour Biol; 2016 Jul; 37(7):8555-66. PubMed ID: 26733173
[TBL] [Abstract][Full Text] [Related]
18. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.
Sanna V; Pintus G; Roggio AM; Punzoni S; Posadino AM; Arca A; Marceddu S; Bandiera P; Uzzau S; Sechi M
J Med Chem; 2011 Mar; 54(5):1321-32. PubMed ID: 21306166
[TBL] [Abstract][Full Text] [Related]
19. Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
Sartor L; Pezzato E; Donà M; Dell'Aica I; Calabrese F; Morini M; Albini A; Garbisa S
Int J Cancer; 2004 Dec; 112(5):823-9. PubMed ID: 15386368
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy.
Zhang G; Wang Y; Zhang Y; Wan X; Li J; Liu K; Wang F; Liu K; Liu Q; Yang C; Yu P; Huang Y; Wang S; Jiang P; Qu Z; Luan J; Duan H; Zhang L; Hou A; Jin S; Hsieh TC; Wu E
Curr Mol Med; 2012 Feb; 12(2):163-76. PubMed ID: 22280355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
